Positive Airway Pressure Devices Market Segment Analysis By Product Type ,Region And Forecast Till  2025

18/set/2020 09:06:11 Grand View Research Contatta l'autore

Questo comunicato è stato pubblicato più di 30 giorni fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Positive Airway Pressure Devices Market

San Francisco, 18 Sep 2020: The Report Positive Airway Pressure Devices Market Size, Share & Trends Analysis Report By Product Type (CPAP, APAP, BiPAP), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), And Segment Forecasts, 2019 - 2025

The global positive airway pressure devices market size is anticipated to reach USD 2.7 billion by 2025, expanding at a CAGR of 7.0%, according to a new report by Grand View Research, Inc. An increase in the patient pool suffering from Obstructive Sleep Apnea (OSA) is one of the key factors anticipated to drive the market growth. Furthermore, an increase in the compliance rate of positive airways pressure (PAP) machines due to growing awareness for sleep apnea and its associated disorders is likely to drive growth over the forecast period. However, the availability of alternative treatment options such as nasal surgery, uvulopalatopharyngoplasty (UPPP), and mandibular maxillomandibular advancement surgery and the on-going clinical trials for the development of sleep apnea medications are some of the major challenges to the market growth.

In 2018, the CPAP device dominated the market, with a revenue of USD 1.3 billion. The penetration of CPAP is increasing owing to improved patient outcomes and favorable reimbursement policies across various countries. Moreover, the launch of portable travel-friendly CPAP machines has also influenced the growth of this segment. On the other hand, the BiPAP device is expected to exhibit the fastest growth rate over the forecast period, owing to its higher efficiency compared to other PAP devices.

North America dominated the market in 2018, with a revenue share of 47.4%, owing to the presence of a large patient pool in the region. Furthermore, the presence of major players and increasing awareness related to OSA and its consequences are some of the secondary factors driving the growth in this region. Moreover, the region is anticipated to grow at the fastest rate over the forecast period, due to high healthcare expenditure and availability of medical insurance coverage in the region.

Access Research Report of Positive Airway Pressure Devices Market https://www.grandviewresearch.com/industry-analysis/positive-airway-pressure-devices-market

Recent Developments in Positive Airway Pressure Devices Market

  • In September 2020, ResMed announced the launch of its AirTouch N20 CPAP nasal mask with a memory foam cushion. AirTouch N20 uses patented UltraSoft memory foam cushion also found in the full-face AirTouch F20 mask in 2017. The masks both adapt to the curves and contours of each individual face, offering a personalized fit to increase comfort and CPAP adherence. It is uniquely comfortable, adapts to give everyone a personalized fit, and doesn’t need cleaning. It’s ideal for nasal CPAP users and their providers. New products like these in the market is set to keep the growth rate of the market ticking in its favour.
  • In March 2020, FDA recommended the usage of CPAP, BPAP and APAP as considered alternative combatants against coronavirus, due to shortage of ventilators. This was recommended with needed precautions and were told to be capable of doing the work of the ventilators. This recommendation boosted the sale of positive airway pressure devices and led to increase in the market growth rate of the devices.
  • In September 2019, Royal Philips introduced a prescription sleep position therapy device called NightBalance to help people with positional obstructive sleep apnoea (OSA). Named Philips NightBalance, it delivers positional therapy by sending gentle vibrations to encourage patients to changes their sleeping positions in order to prevent apnoeas. The device is designed to provide a mask-free alternative to current positional OSA therapies. It comes with wireless connectivity and a mobile app to track its use. It is expected to help treat positional OSA patients who did not experience an adequate response to other therapies. The device has been evaluated in several clinical studies.
  • In March 2019, ResMed launched its automated ResMed ReSupply solution for all U.S. home medical equipment (HME) providers to increase sleep apnea patients’ long-term therapy adherence and improve patient satisfaction. It is a follow-up initiative by the company to make sure the adherence to the commitment of PAP by the patient is maintained for their own benefit. Patients enrolled in an automated resupply program are 50 percent less likely to stop PAP (positive airway pressure) therapy within the first year. Therefore, ResMed has now taken a step towards automated enrolment for those patients who meet compliance requirements. Initiatives like this are sure to benefit patients maintain there commitment and also help the market in maintaining demands.
  • In February 2019,Royal Philips, a global leader in health technology announced a 'No-cost EMI' offer on its products under the Respironics range of sleep and respiratory solutions in India. These solutions tend to assist patients suffering from Chronic Obstructive Pulmonary Disease (COPD), a lung disease with long-term breathing problems and Obstructive Sleep Apnea (OSA), a chronic condition where the patient experiences interrupted breathing during sleep. The 'No-cost EMI' scheme on Sleep & Respiratory care products further demonstrates Philips’ efforts to ensure affordable and accessible care to patients in India. Initiatives like these are bound to boost the demand for the products in the market and improve its growth rate in the region.
  • In November 2018, Aeroflow Healthcare, an Inc. 5000 fastest growing company, announced the acquisition of Integrity Medical’s positive airway pressure resupply line of business to provide more patients with their continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) supplies on a regular basis. Upon acquiring Integrity Medical’s PAP line in Augusta, GA, Aeroflow tended to further its ongoing mission of providing optimal care for even more patients by incorporating Integrity Medical patients into its streamlined resupply program, and by adhering to their customized replacement schedules. Integrity Medical received funds that it reallocated to grow core areas of its business and support high levels of patient care. It played out to be a win-win situation for both the companies and the PAP market.

Access Press Release of Positive Airway Pressure Devices Market @ https://www.grandviewresearch.com/press-release/global-positive-airway-pressure-devices-market

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl